Literature DB >> 19480934

Somatic mitochondrial mutations in pilocytic astrocytoma.

Maria Lueth1, Lena Wronski, Almut Giese, Renate Kirschner-Schwabe, Torsten Pietsch, Andreas von Deimling, Guenter Henze, Andreas Kurtz, Pablo Hernáiz Driever.   

Abstract

The most common brain tumors in childhood and adolescence are low grade pilocytic astrocytomas (PA). Given that an increasing number of mitochondrial defects have been related to brain tumors and cancer in general, we asked whether PAs harbor mutations of mitochondrial DNA (mtDNA). Sequencing analysis of the complete mitochondrial genome of tumor tissue and corresponding blood samples from 19 patients with PA was performed. Of the 19 PA tissue samples, 16 (84%) showed somatic mtDNA mutations, and a total of 34 different somatic mtDNA mutations were identified. Of the 34 mtDNA mutations, 17 (50%) were found in genomic regions involved in pathways of oxidative phosphorylation. Three of the missense mutations in protein coding regions involved change of one amino acid: M60 V in ATP synthase subunit 6, L236I in cytochrome b, and L112 M in cytochrome c oxidase subunit 1. We were able to demonstrate that mtDNA mutations occur in PA and that they are frequently located in protein coding regions. The PA tumors were found to have the highest percentage of mitochondrial mutations of any of the neuroectodermal tumor entities studied to date. To reveal the prognostic importance of these mutations in the tumor biology of PA, larger series need to be studied prospectively.

Entities:  

Mesh:

Year:  2009        PMID: 19480934     DOI: 10.1016/j.cancergencyto.2009.03.002

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Identification of sequence polymorphisms in the mitochondrial cytochrome c oxidase genes as risk factors for hepatocellular carcinoma.

Authors:  Hongfang Wang; Jinsheng Xu; Demao Li; Shenglei Zhang; Zhanjun Guo
Journal:  J Clin Lab Anal       Date:  2017-07-13       Impact factor: 2.352

Review 2.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

3.  Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.

Authors:  Stefano Bartesaghi; Vincenzo Graziano; Sara Galavotti; Nick V Henriquez; Joanne Betts; Jayeta Saxena; Valentina Minieri; Deli A; Anna Karlsson; L Miguel Martins; Melania Capasso; Pierluigi Nicotera; Sebastian Brandner; Vincenzo De Laurenzi; Paolo Salomoni
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-12       Impact factor: 11.205

Review 4.  Somatic mitochondrial DNA mutations in cancer escape purifying selection and high pathogenicity mutations lead to the oncocytic phenotype: pathogenicity analysis of reported somatic mtDNA mutations in tumors.

Authors:  Luísa Pereira; Pedro Soares; Valdemar Máximo; David C Samuels
Journal:  BMC Cancer       Date:  2012-02-02       Impact factor: 4.430

5.  Identification and functional prediction of mitochondrial complex III and IV mutations associated with glioblastoma.

Authors:  Rhiannon E Lloyd; Kathleen Keatley; D Timothy J Littlewood; Brigitte Meunier; William V Holt; Qian An; Samantha C Higgins; Stavros Polyzoidis; Katie F Stephenson; Keyoumars Ashkan; Helen L Fillmore; Geoffrey J Pilkington; John E McGeehan
Journal:  Neuro Oncol       Date:  2015-03-02       Impact factor: 12.300

6.  Mitochondrial DNA Mutations in Grade II and III Glioma Cell Lines Are Associated with Significant Mitochondrial Dysfunction and Higher Oxidative Stress.

Authors:  Bee Hong Soon; Nor Azian Abdul Murad; Sue-Mian Then; Azizi Abu Bakar; Farizal Fadzil; Jegan Thanabalan; Mohd S Mohd Haspani; Charng Jeng Toh; Azmi Mohd Tamil; Roslan Harun; Wan Z Wan Ngah; Rahman Jamal
Journal:  Front Physiol       Date:  2017-04-21       Impact factor: 4.566

7.  Detection of somatic mutations in the mitochondrial DNA control region D-loop in brain tumors: The first report in Malaysian patients.

Authors:  Abdul Aziz Mohamed Yusoff; Khairol Naaim Mohd Nasir; Khalilah Haris; Siti Zulaikha Nashwa Mohd Khair; Abdul Rahman Izaini Abdul Ghani; Zamzuri Idris; Jafri Malin Abdullah
Journal:  Oncol Lett       Date:  2017-08-28       Impact factor: 2.967

8.  Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein.

Authors:  Leo Veenman; Julia Alten; Karen Linnemannstöns; Yulia Shandalov; Sivan Zeno; Max Lakomek; Moshe Gavish; Wilfried Kugler
Journal:  Apoptosis       Date:  2010-07       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.